The medication can cost patients and their insurance companies more than $46,000 a year. The board also considered Genvoya, a combination pill for HIV, but determined that medication was ...

possible risk of heart disease Get genetic testing done before you start on this medication. emtricitabine (Emtriva; also included in Biktarvy, Complera, Descovy, Genvoya, Odefsey ...

Five drugs were chosen for review by the board: Enbrel, Genvoya, Cosentyx, Stelara and Trikafta. A Colorado woman who uses one of the drugs is urging the board to use caution as they review it.

The board recently decided that Vertex Pharmaceuticals’ Trikafta and Gilead’s HIV drug Genvoya were affordable, due to patient assistance programs. More on state drug affordability boards here.